Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study

OBJECTIVE: To investigate the effects of combination therapy with cholecalciferol and lansoprazole on residual β-cell function and glycemic control in children with new-onset type 1 diabetes. METHODS: Children aged 6-12 years with type 1 diabetes were allocated to receive cholecalciferol and lansopr...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Raghunatha, Dayal, Devi, Sachdeva, Naresh, Attri, Savita Verma, Gupta, Vinod Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744432/
https://www.ncbi.nlm.nih.gov/pubmed/36449759
http://dx.doi.org/10.31744/einstein_journal/2022AO0149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744432/
https://www.ncbi.nlm.nih.gov/pubmed/36449759
http://dx.doi.org/10.31744/einstein_journal/2022AO0149

Ejemplares similares